Table S1. Literature overview CSF immune markers in AD clinical groups. (DOCX 72 kb
Table S1. Overview of median blood cell counts and blood cell-based ratios measured per Rotterdam St...
Table presenting correlation results of CSF SOMAscan proteins with CSF markers of AD pathology (CSV ...
Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...
Figure S2. Between-group comparisons of microglial- and astroglial activation with inflammation base...
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Results of multiple linear regression models without control for confounding variables. Values are β...
Table S6. Top AD risk genes in Blue, Magenta and Yellow AD-associated microglial modules. (XLSX 22Â ...
Results of multiple linear regression models with control for confounding variables. Values are β co...
Table S5. Enrichment analysis of GWAS-identified human AD-risk genes in mouse microglial modules. (X...
Table S1. Mouse microglial transcriptomic modules identified by Weighted Correlation Network Analysi...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S1. Enrichment of AD-risk variants at DHSs from Roadmap Epigenomics Consortium data. (XLSX 36 ...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Table S3. Identification of potential transcriptional regulators of mouse microglial modules. (XLSX ...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
Table S1. Overview of median blood cell counts and blood cell-based ratios measured per Rotterdam St...
Table presenting correlation results of CSF SOMAscan proteins with CSF markers of AD pathology (CSV ...
Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...
Figure S2. Between-group comparisons of microglial- and astroglial activation with inflammation base...
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Results of multiple linear regression models without control for confounding variables. Values are β...
Table S6. Top AD risk genes in Blue, Magenta and Yellow AD-associated microglial modules. (XLSX 22Â ...
Results of multiple linear regression models with control for confounding variables. Values are β co...
Table S5. Enrichment analysis of GWAS-identified human AD-risk genes in mouse microglial modules. (X...
Table S1. Mouse microglial transcriptomic modules identified by Weighted Correlation Network Analysi...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S1. Enrichment of AD-risk variants at DHSs from Roadmap Epigenomics Consortium data. (XLSX 36 ...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Table S3. Identification of potential transcriptional regulators of mouse microglial modules. (XLSX ...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
Table S1. Overview of median blood cell counts and blood cell-based ratios measured per Rotterdam St...
Table presenting correlation results of CSF SOMAscan proteins with CSF markers of AD pathology (CSV ...
Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...